Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study

Update Il y a 4 ans
Reference: NCT00443105

Woman and Man

  • | Country :
  • Israel
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine the efficacy, tolerance and safety of tacrolimus 0.03% ointment in the treatment of intractable allergic conjunctivitis.


Inclusion criteria

  • allergic conjunctivitis

Links